| Name | Title | Contact Details |
|---|
Nu Image Medical specializes in Weight Loss, Hormone Replacement, Sexual Enhancement and General Wellness. Our futuristic methods offer a new and updated approach to achieving optimum health and wellness not only through local brick-and-mortar establishments, but also online virtually through our telemedicine platform. Nu Image Medical has been proving patient services nationally since 2004, establishing itself as not on a leader in Regenerative Medicine, but also in the Telehealth industry. Nu Image Medical sets the standard for patients looking to receive quality expert medical care without boundaries.
At Clinipace, a global, full-service contract research organization (CRO), our approach to clinical research is personal. We deliver a level of collaboration and flexibility not possible in a traditional CRO environment. Our personalized services and solutions, local regulatory expertise and therapeutic leadership are designed to face the most difficult industry challenges across all major therapeutic areas including oncology, gastroenterology, nephrology and urology. We strive to improve the way clinical research is performed and impact the future of health care using the most advanced technology and a CHALLENGE ACCEPTED approach. In April 2021, Clinipace & dMed merged creating a differentiated mid-size CRO with the largest Asia-Pacific presence. We are proud to have such a strong group of global investors focused on improving healthcare outcomes and giving sponsors a better CRO choice. dMed`s 2019 acquisition of Target Health commenced the process of building a Next Generation global CRO for biotech and pharmaceutical companies. Our investors have invested over $230M to build the next great global CRO. dMed`s acquisition of Target Health in 2019 began dMed`s evolution from a local to global CRO. Target Health LLC is owned by dMedClinical Co. Ltd., a privately held company that is majority owned, operated, managed, and controlled by a U.S. citizen and foreign entities located in the People`s Republic of China. Dr. Lingshi Tan, is the aforementioned U.S. citizen currently residing in Shanghai, China. Dr. Tan moved to Shanghai (from New York) to become Pfizer`s VP of Worldwide Development Operations, and Chairman and General Manager of Pfizer (China) Research & Development Co. Dr. Tan founded dMed in 2016 to satisfy the local demand for a high quality, responsive, flexible CRO.
Bio-Vin Research Laboratories is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Path is a healthcare company powered by technology. We`re a teletherapy company that doesn`t compromise on quality — we measure progress and prioritize patient outcomes. Path takes a patient-first approach, where treatment is more accessible, personalized, and effective. With Path, it`s easy to find a high-quality therapist or psychiatric practitioner who meets your unique needs, accepts insurance, and is taking new patients. For providers, Path offers the flexibility of private practice, while also filling caseloads and offering the necessary behind-the-scenes support. Path handles the marketing, credentialing, billing, and admin tasks so providers can focus on what they love: providing care to those in need. With no minimum caseload required and guaranteed payments, Path is a trusted partner for more than 8,000 therapists nationwide and has hundreds of 5-star reviews. Our mission is to make mental healthcare work for everyone. Path is a 100% remote healthtech company and we`re hiring! We have teams who specialize in the areas of Clinical, Finance, Operations, Marketing, Engineering, Product, and more. We`re excited to bring people onto the team who are committed to changing how mental health is treated.
The purpose of the Healthcare Foundation is to support the work and mission of Glendale Adventist Medical Center through philanthropy. Foundation responsibilities include the receipt and disbursement of all gifts to the Medical Center, as well as the